ozone autohemotherapy linked to meaningful gains in lung capacity and airflow
Ozone major autohemotherapy at 8 mg significantly improved forced vital capacity (FVC) from 2.34 to 2.99 L and FEV1 from 1.46 to 2.20 L (and from 46.00% to 73.25% predicted) in asthma patients.
What this means for you
Lung capacity and how much air you can move in one breath are two of the clearest signals of respiratory health. When these numbers improve, everyday activities like climbing stairs, exercising, or simply breathing deeply tend to feel noticeably easier — and your body's ability to deliver oxygen to every cell goes up with them.
The published research
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.